Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: CACI stock price vs EW: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at EW's multiple
Needs EW P/E.
Implied fair value · at CACI's multiple
Needs CACI P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Multiple discount
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: CACI FY 2026 (ended Jun 30, 2026) · EW FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 74% equity / 26% debt · EV / Revenue 1.94x · EV / EBITDA 17.07x
Capital structure 99% equity / 1% debt · EV / Revenue 7.94x · EV / EBITDA 32.28x
EW carries the larger enterprise value at $48.19B against $18.54B; CACI trades on the lower EV / Revenue multiple (1.94x vs 7.94x); CACI on the lower EV / EBITDA (17.07x vs 32.28x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
CACI INTERNATIONAL INC · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Edwards Lifesciences Corporation · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.11x
0.06x
Net debt / EBITDA
Leverage against operating earnings
4.38x
-2.43x
Cash and equivalents
Liquid reserves on the balance sheet
$191.76M
$4.23B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Science Applications International Corp
CACI vs SAIC
KBR, INC.
CACI vs KBR
Booz Allen Hamilton Holding Corp
CACI vs BAH
Leidos Holdings, Inc.
CACI vs LDOS
JACOBS SOLUTIONS INC.
CACI vs J
ABBOTT LABORATORIES
CACI vs ABT
JOHNSON & JOHNSON
CACI vs JNJ
Medtronic plc
CACI vs MDT
BOSTON SCIENTIFIC CORP
CACI vs BSX
BAXTER INTERNATIONAL INC
CACI vs BAX
DENTSPLY SIRONA Inc.
CACI vs XRAY
$4.95B
$598.30M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
